New Owner
GSK (GlaxoSmithKline) - Okairos
GSK (GlaxoSmithKline) acquires Okairos
Announced: May 29, 2013
Type: Acquisition
Disposition: Subsidiary
Status: Complete
Amount: $ 325,000,000